$AUPH, $TDOC - On our trading list with news today or analyst comments with our opinion & trade ideas.Aurinia Pharma called the best idea for 2021. Teladoc initiated with a neutral by Goldman.Cowen calls Aurinia a best idea for 2021 into FDA action dateAurinia Pharmaceuticals is positioned for a "meaningful inflection" into the January 22 FDA action date for voclosporin in lupus nephritis, Cowen analyst Ken Cacciatore tells investors in a research note. Citing voclosporin's efficacy and safety, combined with clinician enthusiasm and an unmet clinical need, the analyst has "strong conviction" that voclosporin should be "rapidly incorporated" into the standard of care and has $1B-PLUS sales potential. He calls Aurinia a best for 2021 and recommends adding to positions at current levels. Cacciatore keeps an Outperform rating on the shares with a $30 price target.Our Take: AUPH us on our favorites list and has great potential! A good buy at current levels or anytime under $15. $AUPH, Aurinia Pharmaceuticals Inc / H1 Teladoc initiated with a Neutral at Goldman SachsGoldman Sachs analyst Robert Jones initiated coverage of Teladoc Health with a Neutral rating and $206 price target. The analyst says the shares already trade above the comp median, which creates a "more challenging path to upside." Meaningful upside within the legacy Teladoc business lies on U.S. membership growth in Health Plan lives, which possess some risk, Jones tells investors in a research note. Outside of legacy Teladoc, upside would be driven by synergies, and legacy Livongo, "where there is less of a track record," adds the analyst.Our Take: This in the past has been a big winner for us. We do agree with Goldman now, this has gotten a bit high. If you own it, taking some profits or selling some covered calls is a good idea.Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .Are you interested in trading stocks to supplement your income or make a living? Maybe become a professional trader? Many traders have the skills and nerves to trade, but not the upfront capital. Well now that problem is solved!Try2BeFunded has expanded its trading program! If you're a novice or experienced trader, you can earn access to a trading account with up to $100,000! To learn more about how to qualify, click HERE and give it a shot! You have nothing to lose it is free to try. Trade Try2BeFunded today! .